Coca-Cola FEMSA, S.A.B. de C.V. (COCSF)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	17,527	16,363	19,882	14,260	11,510	9,685
Market Cap Growth	12.69%	-17.70%	39.42%	23.89%	18.85%	-23.95%
Enterprise Value	20,686	18,643	22,212	16,552	13,590	12,038
Last Close Price	8.23	7.40	8.97	6.58	5.17	4.10
PE Ratio	14.02	14.37	17.21	14.61	15.02	18.70
PS Ratio	1.14	1.22	1.37	1.23	1.21	1.05
PB Ratio	2.28	2.27	2.51	2.11	1.85	1.57
P/TBV Ratio	9.78	8.21	13.00	12.50	12.18	14.94
P/FCF Ratio	38.61	18.43	14.82	14.85	10.09	7.56
P/OCF Ratio	10.02	8.03	7.95	7.84	7.21	5.48
EV/Sales Ratio	1.35	1.39	1.53	1.42	1.43	1.31
EV/EBITDA Ratio	7.74	8.11	8.90	8.23	7.84	6.90
EV/EBIT Ratio	10.16	10.37	11.40	10.77	10.33	9.47
EV/FCF Ratio	45.57	21.00	16.56	17.23	11.92	9.40
Debt / Equity Ratio	0.61	0.53	0.53	0.65	0.68	0.73
Debt / EBITDA Ratio	1.78	1.64	1.65	2.15	2.41	2.53
Debt / FCF Ratio	10.39	4.33	3.12	4.57	3.73	3.51
Asset Turnover	0.96	0.96	0.89	0.83	0.73	0.71
Inventory Turnover	11.38	11.65	11.30	9.93	8.56	8.76
Quick Ratio	0.85	0.87	0.99	1.08	1.42	1.41
Current Ratio	1.12	1.12	1.23	1.37	1.74	1.69
Return on Equity (ROE)	17.59%	17.27%	15.23%	15.13%	13.06%	8.22%
Return on Assets (ROA)	7.86%	8.05%	7.46%	6.82%	6.31%	6.07%
Return on Capital (ROIC)	10.68%	10.76%	9.76%	8.67%	7.90%	7.62%
Return on Capital Employed (ROCE)	15.50%	15.60%	15.10%	13.60%	12.00%	11.50%
Earnings Yield	7.13%	6.96%	5.81%	6.84%	6.66%	5.35%
FCF Yield	2.59%	5.42%	6.75%	6.73%	9.91%	13.23%
Dividend Yield	4.20%	47.76%	40.10%	45.22%	51.20%	61.80%
Payout Ratio	57.81%	53.83%	62.37%	59.93%	67.41%	99.06%
Total Shareholder Return	4.20%	47.76%	40.10%	45.22%	51.20%	61.80%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.